Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Information Collection Request Title: Office for the Advancement of Telehealth Outcome Measures, OMB No. 0915-0311-Revision, 49660-49661 [2020-17787]
Download as PDF
<![CDATA[
49660
Federal Register / Vol. 85, No. 158 / Friday, August 14, 2020 / Notices
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Type of
respondent
Number of
recordkeepers
Number of
records per
recordkeeper
Total annual
records
Average burden per
recordkeeper
Total hours
Domestic facilities ....................................................
Foreign facilities .......................................................
697
916
52
52
36,244
47,632
0.25 (15 minutes) ......
0.25 (15 minutes) ......
9,061
11,908
Total ..................................................................
........................
........................
........................
....................................
20,969
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Based on a review of the information
collection since our last request for
OMB approval, we have made no
adjustments to our burden estimate.
Dated: August 10, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2020–17876 Filed 8–13–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request; Information Collection
Request Title: Office for the
Advancement of Telehealth Outcome
Measures, OMB No. 0915–0311—
Revision
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period. OMB may act on
HRSA’s ICR only after the 30 day
comment period for this notice has
closed.
SUMMARY:
Comments on this ICR should be
received within 30 days of this notice
no later than September 14, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
HRSA Telehealth Outcome Measures
OMB No. 0915–0311—Revision.
Abstract: In order to help carry out its
mission, the Office for the Advancement
of Telehealth (OAT) created a set of
performance measures that grantees can
use to evaluate the effectiveness of their
services programs and monitor their
progress through the use of performance
reporting data.
A 60-day Notice was published in the
Federal Register on March 26, 2020,
vol. 85, No. 59; p. 17089. There were no
comments.
Need and Proposed Use of the
Information: As required by the
Government Performance and Results
Act of 1993, all federal agencies must
develop strategic plans describing their
overall goal and objectives. The Federal
Office of Rural Health Policy, OAT, has
worked with its grantees to develop
performance measures to be used to
DATES:
evaluate and monitor the progress of the
grantees. Grantee goals are to: Improve
access to needed services; reduce rural
practitioner isolation; improve health
system productivity and efficiency; and
improve patient outcomes. In each of
these categories, specific indicators
were designed to be reported through a
performance monitoring website. New
measures are being added to the
Telehealth Network Grant Program to
capture awardee-level and aggregate
data that illustrate the impact and scope
of federal funding along with assessing
these efforts. The measures speak to
OAT’s progress toward meeting the
goals, specifically telehealth services
delivered through Emergency
Departments.
Likely Respondents: Telehealth
Network Grantees.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
khammond on DSKJM1Z7X2PROD with NOTICES
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total
burden
hours
Performance Improvement Measurement System (PIMS) ..
29
1
29
7
203
Total ..............................................................................
29
........................
29
........................
203
VerDate Sep<11>2014
17:29 Aug 13, 2020
Jkt 250001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\14AUN1.SGM
14AUN1
Federal Register / Vol. 85, No. 158 / Friday, August 14, 2020 / Notices
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–17787 Filed 8–13–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
Findings of research
misconduct have been made against
Rahul Dev Jayant, Ph.D. (Respondent),
Assistant Professor Pharmaceutical
Sciences, School of Pharmacy, Texas
Tech University Health Science Center
(TTUHSC). Dr. Jayant engaged in
research misconduct in research
supported by U.S. Public Health Service
(PHS) funds, specifically National
Institute on Drug Abuse (NIDA),
National Institutes of Health (NIH),
grant R03 DA044877. The
administrative actions, including
supervision for a period of three (3)
years, were implemented beginning on
July 27, 2020, and are detailed below.
FOR FURTHER INFORMATION CONTACT:
Elisabeth A. Handley, Director, Office of
Research Integrity, 1101 Wootton
Parkway, Suite 240, Rockville, MD
20852, (240) 453–8200.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Office of Research
Integrity (ORI) has taken final action in
the following case:
Rahul Dev Jayant, Ph.D., Texas Tech
University Health Science Center: Based
on the report of an inquiry conducted by
TTUHSC and additional analysis
conducted by ORI in its oversight
review, ORI found that Dr. Jayant,
Assistant Professor Pharmaceutical
Sciences, School of Pharmacy,
TTUHSC, engaged in research
misconduct in research supported by
PHS funds, specifically NIDA, NIH,
grant R03 DA044877.
ORI found that Respondent engaged
in research misconduct by intentionally
plagiarizing, falsifying, and/or
fabricating data included in the
following grant applications submitted
for PHS funds:
• R21 DA051845–01, ‘‘DAT–CNS
Organoid-Chip Model to Characterize
the Effects of Buprenorphine on Fetal
Neurodevelopment,’’ submitted to
NIDA, NIH, on October 16, 2019.
• R01 DA051894–01, ‘‘Novel 3D
Printed CNS-Organoid Chip Model to
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:29 Aug 13, 2020
Jkt 250001
Elucidate HAND,’’ submitted to NIDA,
NIH, on November 12, 2019.
• R21 DA052445–01, ‘‘3D Printed
Microfluidic Chip Cerebral Organoids
(3D–MCCO) to Decode
Neurodevelopmental Deficits with
Oxycodone Exposure,’’ submitted to
NIDA, NIH, on February 10, 2020.
• R21 AA028877–01, ‘‘3D Printed
CNS-Organoid Chip Model to Identify
Biomarkers for Prenatal Alcohol
Exposure,’’ submitted to the National
Institute on Alcohol Abuse and
Alcoholism (NIAAA), NIH, on February
13, 2020.
ORI found that Respondent engaged
in research misconduct by intentionally:
• Plagiarizing four (4) images of brain
organoids and one (1) graph from Nat
Protoc. 2014 Oct; 9(10):2329–40
(hereafter referred to as ‘‘NP 2014’’)
without author attribution and
including the plagiarized material in
Figure 3iia–c of R21 DA051845–01,
Figure 2iiia–c of R01 DA051894–01,
Figure 3iiia–c of R21 DA052445–01,
Figure 3iiia–c of R21 AA028877–01, and
the graph in Figure 2iv of R01
DA051894–01.
• Plagiarizing one (1) image of brain
organoids from Nature Communications
2018 Oct 9; 9(1):4167 (hereafter referred
to as ‘‘NC 2018’’) without author
attribution and including the
plagiarized material in Figure 2iiid of
R01 DA051894–01.
• Falsifying and fabricating three (3)
figures representing experiments
measuring caspase3 expression in
human brain organoids by reusing data
from one experiment to represent
different experimental treatments in
Figure 4Bii of R21 DA051845–01, Figure
4iv of R21 DA052445–01, and Figure
3iii of R21 DA051894–01.
• Fabricating nine (9) bar graphs
representing experiments measuring
gene expression in control and
experimental samples of human brain
organoids treated with drugs of abuse in
Figures 2i and 3i–iii of R21 DA051894–
01, Figures 3ii, 4Ai–ii, and 4Bii of R21
AA028877–01, Figures 3ii and 4i–iii of
R21 DA052445–01, and Figures 4A, 4Bi,
and 5 of R21 DA051845–01.
Specifically, ORI found that
Respondent intentionally:
• Plagiarized confocal images of
immuno-stained samples of human
brain organoids from Figure 4 of NP
2014, and the plagiarized images were
cropped, rotated, contrast enhanced and
labeled with scale bars in:
—Figure 3iia–c in R21 DA051845–01
—Figure 2iiia–c in R01 DA051894–01
—Figure 3iiia–c in R21 DA052445–01
—Figure 3iiia–c in R21 AA028877–01
• Plagiarized confocal images of
immuno-stained samples of human
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
49661
brain organoids from Figure 1e of NC
2018 in Figure 2iiid in R01 DA051894–
01. The plagiarized image was cropped
and rotated and the contrast was altered.
• Plagiarized the graph in Figure 2iv
in R01 DA051894–01 representing
measurements of gene expression and
associated statistics in cultured human
brain organoids. The source of the
plagiarized graph is unknown.
• Plagiarized the graph in Figure 2iv
in R01 DA051894–01 representing
measurements of gene expression and
associated statistics in cultured human
brain organoids. The source of the
plagiarized graph is unknown.
• Falsified and fabricated control and
experimental data representing
measurements of caspase3 mRNA
expression in human brain organoids
treated with drugs of abuse. The
identical images were falsely relabeled
to represent different experimental
treatments that were never done. The
identical panels are:
—Figure 4Bii, labeled as
‘‘Buprenorphine (5 mM),’’ in R21
DA051845–01
—Figure 4iv, labeled as ‘‘Oxy 10 mM,’’
in R21 DA052445–01
—Figure 3iii, labeled as ‘‘Meth-10mM,’’
in R21 DA051894–01
• Falsified Figure 4Bi in R21
AA028877–01 to represent control and
experimental data measuring neurite
outgrowth in cultured human neurons
treated with ethanol. The panels in
Figure 4Bi in R21 DA051894–01,
labeled as control or treated with 10ng/
ml Tat for 1 or 7 days, are identical to
those in Figure 4Bi in R21 AA028877–
01, which were falsely relabeled as
control or treated with 10 or 40 mM
EtOH.
• Fabricated quantitative data and
associated statistics representing
measurements of gene expression levels
in cultured human brain organoids over
time or treated with drugs of abuse.
The fabricated bar graphs are:
—Figures 2i and 3i–iii in R21
DA051894–01
—Figures 3ii, and 4Ai–ii, and 4Bii in
R21 AA028877–01
—Figures 3ii and 4i–iii in R21
DA052445–01
—Figures 4A, Bi, and 5 in R21
DA051845–01
Dr. Jayant entered into a Voluntary
Settlement Agreement and agreed to the
following:
(1) Respondent agreed to have his
research supervised for a period of three
(3) years beginning on July 27, 2020.
Respondent agreed that prior to the
submission of an application for PHS
support for a research project on which
Respondent’s participation is proposed
E:\FR\FM\14AUN1.SGM
14AUN1
]]>Agencies
[Federal Register Volume 85, Number 158 (Friday, August 14, 2020)]
[Notices]
[Pages 49660-49661]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17787]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request; Information Collection
Request Title: Office for the Advancement of Telehealth Outcome
Measures, OMB No. 0915-0311--Revision
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with of the Paperwork Reduction Act of 1995,
HRSA has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period. OMB may act on HRSA's ICR only after the 30
day comment period for this notice has closed.
DATES: Comments on this ICR should be received within 30 days of this
notice no later than September 14, 2020.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under Review--Open for
Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email the HRSA Information
Collection Clearance Officer at [email protected] or call (301) 443-
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: HRSA Telehealth Outcome
Measures OMB No. 0915-0311--Revision.
Abstract: In order to help carry out its mission, the Office for
the Advancement of Telehealth (OAT) created a set of performance
measures that grantees can use to evaluate the effectiveness of their
services programs and monitor their progress through the use of
performance reporting data.
A 60-day Notice was published in the Federal Register on March 26,
2020, vol. 85, No. 59; p. 17089. There were no comments.
Need and Proposed Use of the Information: As required by the
Government Performance and Results Act of 1993, all federal agencies
must develop strategic plans describing their overall goal and
objectives. The Federal Office of Rural Health Policy, OAT, has worked
with its grantees to develop performance measures to be used to
evaluate and monitor the progress of the grantees. Grantee goals are
to: Improve access to needed services; reduce rural practitioner
isolation; improve health system productivity and efficiency; and
improve patient outcomes. In each of these categories, specific
indicators were designed to be reported through a performance
monitoring website. New measures are being added to the Telehealth
Network Grant Program to capture awardee-level and aggregate data that
illustrate the impact and scope of federal funding along with assessing
these efforts. The measures speak to OAT's progress toward meeting the
goals, specifically telehealth services delivered through Emergency
Departments.
Likely Respondents: Telehealth Network Grantees.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this Information Collection Request are summarized in the table below.
Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total burden per Total burden
Form name respondents responses per responses response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Performance Improvement 29 1 29 7 203
Measurement System (PIMS)......
-------------------------------------------------------------------------------
Total....................... 29 .............. 29 .............. 203
----------------------------------------------------------------------------------------------------------------
[[Page 49661]]
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-17787 Filed 8-13-20; 8:45 am]
BILLING CODE 4165-15-P
